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Abstract
Nitric oxide can both promote and inhibit lipid peroxidation. By itself, nitric oxide acts as a potent inhibitor of the lipid
peroxidation chain reaction by scavenging propagatory lipid peroxyl radicals. In addition, nitric oxide can also inhibit many
potential initiators of lipid peroxidation, such as peroxidase enzymes. However, in the presence of superoxide, nitric oxide
forms peroxynitrite, a powerful oxidant capable of initiating lipid peroxidation and oxidizing lipid soluble antioxidants. The
role of nitric oxide in vascular pathology is discussed. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Oxidative stress can be considered to occur when
the £ux of partially reduced forms of oxygen is great-
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er than the ability of the biological system to cope
with their production. Under stressed conditions,
biological molecules are exposed to pro-oxidant spe-
cies resulting in irreversible oxidation reactions. Such
reactions result in chemical modi¢cation of biologi-
cal molecules that can lead to cellular dysfunction.
Oxidative damage to nuclear DNA can result in gene
mutation and is thought to be one cause of carcino-
genesis [1,2]. Protein oxidative damage is generally
less of a concern as most proteins turn over rapidly.
However, in situations such as the lens, where the
crystallins have a slow turnover rate, oxidative dam-
age will be cumulative and is thought to lead to
cataract development [3]. In addition, the ‘redox sta-
tus’ of a cell, which refers to the ratio of the reduced
and oxidized forms of certain cellular components
(e.g., glutathione), is an important signaling device
in cellular homeostasis [4]. It follows that any addi-
tional oxidative insult that changes the redox-status
of the cell will consequently alter the expression and
activity of cellular metabolic pathways.
Lipid bilayer membranes de¢ne the extent of cells
and organelles. The permeability characteristics of
the bilayer allow gradients of metabolite and electro-
lyte concentrations to exist between the intra- and
extracellular spaces. Any loss in membrane integrity
due to lipid damage will rapidly dissipate these gra-
dients and compromise cellular function. For exam-
ple, the loss and the inner mitochondrial membrane
permeability barrier would preclude the establish-
ment of a proton gradient and prevent ATP synthe-
sis. Lipids are also subject to turnover under normal
conditions, and damaged lipids can be reprocessed
and repaired. However, many of the products of lipid
oxidation, such as hydroperoxides, alcohols, alde-
hydes and F2-isoprostanes, have biological activities
beyond concerns about barrier function [5,6]. In ad-
dition, lipid oxidation is a chain reaction. A single
oxidative event can oxidize many lipid molecules. In
the presence of iron or copper ions, the chain reac-
tion can become a cascade and the oxidation process
can rapidly become unstoppable [7]. Biological strat-
egies against lipid peroxidation involve both prevent-
ing the initial oxidation and breaking the chain be-
fore much damage is done.
This review will focus on the role of nitric oxide
in promoting and inhibiting lipid oxidation reac-
tions.
2. Mechanism of lipid oxidation
Polyunsaturated fatty acids have a propensity to
oxidize, resulting in the formation of alkanes, alde-
hydes, alcohols, and hydroperoxides among other
products. This propensity arises from the fact that
bis-allylic methylene hydrogens are more susceptible
to hydrogen abstraction by oxidizing radicals than
are the methylene hydrogens from fully saturated
lipids. This is partially due to the fact that the result-
ing free radical has multiple resonance structures that
increase its stability (Scheme 1). In the more heavily
populated of these structures the double bonds are
conjugated and the radical resides on an adjacent
methylene carbon. The rapid reaction of these reso-
nance forms with oxygen ‘¢xes’ the double bonds in
a conjugated arrangement to form peroxyl radicals at
positions +2 and 32 with respect to the carbon atom
from which the original abstraction occurred
(Scheme 1). For example, oxidation of linolenic
acid by hydrogen abstraction at carbon-11 can result
in peroxyl radicals at both the 9- and 13-position.
The conjugation of the double bond results in a
red-shift of the UV absorbance spectrum to give a
maximum at 234 nm. This change is often employed
in vitro and in vivo to detect and quantify lipid ox-
idation.
Scheme 1. Lipid peroxidation. Abstraction of an allylic hydro-
gen and conjugated diene formation.
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The lipid peroxyl radical is the central species of
the lipid peroxidation chain reaction. This radical
can abstract a bis-allylic hydrogen from an adjacent
fatty acid to form a lipid hydroperoxide and a sec-
ond lipid radical (Eq. 1), which subsequently reacts
with oxygen to regenerate a peroxyl radical (Eq. 2).
LOOc LH! LOOH Lc 1
LcO2 ! LOOc 2
These reactions are the chain-propagation steps of
lipid peroxidation. Eq. 1 is rate limiting and so the
rate of the propagation reaction is proportional to
the concentration of lipid peroxyl radicals. Conse-
quently any reaction that alters the concentration
of peroxyl radicals will a¡ect the rate of lipid perox-
idation.
3. Factors a¡ecting lipid peroxyl radical concentration
Lipid peroxyl radical concentration can be altered
by a number of factors.
3.1. Transition metal ions
A few ions of transition metal elements have redox
transitions with potentials of a magnitude that allows
the catalytic decomposition of hydroperoxides. The
redox couples of most importance to biological sys-
tems are Cu/Cu2 and Fe2/Fe3. The one electron
redox cycle results in the formation of peroxyl and
alkoxyl radicals [8], the latter of which rearrange and
react with oxygen to form peroxyl radicals [9]. By
this mechanism, transition metal ions increase the
concentration of peroxyl radicals and accelerate lipid
peroxidation. As lipid peroxidation generates lipid
hydroperoxides, the e¡ect of transition metal ions
is autocatalytic. This behavior is observed during
copper catalyzed oxidation of low-density lipoprotein
[10,11].
3.2. Termination reactions
In the absence of any additional reactions, the lip-
id peroxidation chain reaction will terminate when
two lipid radicals react to form non-radical products.
These reactions decrease the level of peroxyl radicals
and slow the rate of lipid oxidation. The mechanism
and products of such reactions are complex and only
partially understood. It has been reported that en-
dogenous chemiluminescence is associated with
such reactions, perhaps indicating the formation of
singlet state oxygen [12].
3.3. Antioxidants
As demonstrated in Eq. 1, lipid peroxyl radicals
propagate the chain reaction of lipid peroxidation
by abstracting a hydrogen atom from an unsaturated
fatty acid. It follows that any compound that can
donate a hydrogen atom to the peroxyl radical
should be able to break, or at least divert, the chain
of reaction. Compounds that donate a hydrogen to
leave a relatively inert radical product are referred to
as chain-breaking antioxidants. The most well
known and well-studied chain-breaking antioxidants
are phenolic compounds, such as the natural toco-
pherols [13].
4. The role of nitric oxide in lipid oxidation
As discussed above, the rate of lipid peroxidation
depends strongly on the concentration of peroxyl
radicals. Consequently, any discussion of the role
of nitric oxide in lipid peroxidation can be simpli¢ed
by asking the question ‘how does nitric oxide a¡ect
lipid peroxyl radical concentration?’ This question
can be addressed at several levels.
4.1. Nitric oxide and the initiation of lipid
peroxidation
The mechanisms by which the initiation of lipid
peroxidation occurs in vivo are not well de¢ned but
are likely to be a subset of the mechanisms that have
been carefully studied in vitro [10,14,15]. In addition,
some clearly non-physiological models for the initia-
tion of lipid peroxidation have given invaluable in-
sights into this process [16]. Nitric oxide is not a
strong oxidant and cannot extract a bis allylic hydro-
gen from an unsaturated fatty acid to begin the per-
oxidation chain reaction [14]. However, in combina-
tion with other agents nitric oxide can both promote
and inhibit the initiation of lipid oxidation. The role
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of nitric oxide in the initiation of lipid peroxidation
can be subdivided as follows.
4.1.1. Nitric oxide and pro-oxidant enzymes and
proteins
Several enzymes have the ability to oxidize unsa-
turated fatty acids. The complex pathways of arach-
idonate metabolism to form prostaglandins, leuko-
trienes and related species contain enzymes that
catalyze the introduction of dioxygen, either as an
endoperoxide (in the case of cyclooxygenase) or as
a hydroperoxide (in the case of lipoxygenases). In
addition, several cytochrome P450 type enzymes
are also involved in arachidonate oxidation. Nitric
oxide has been suggested to inhibit these enzymes
by reduction of active site heme or non-heme iron
to an inactive ferrous form [17]. These observations
suggest interplay between the nitric oxide pathway
and arachidonate metabolism.
Lipid oxidation can also be initiated by ferryl he-
moglobin, formed from the interaction of hemoglo-
bin with peroxides. Nitric oxide has been shown to
reduce the ferryl heme and so prevent lipid oxidation
by this mechanism [18,19].
4.1.2. Nitric oxide and glutathione peroxidase
Glutathione peroxidases are glutathione-dependent
seleno peroxidases that catalyze the reduction of hy-
droperoxides to the respective alcohols. It has been
reported that glutathione peroxidase can be inhibited
by the putative nitric oxide donor S-nitroso-N-acetyl
penicillamine (SNAP) in U937 cells and that this in-
hibition leads to an increased level of lipid peroxida-
tion [20]. The mechanism for this e¡ect was deter-
mined to be oxidation of the selenocysteine of the
peroxidase to a selenocystine^cystine bridge [21]. Ni-
tric oxide may thus interfere with the detoxi¢cation
of hydroperoxides once formed.
4.1.3. Nitric oxide and chemical initiators
The hydroxyl radical (cOH) is a highly oxidizing
free radical and will initiate lipid peroxidation by
hydrogen abstraction. Hydroxyl radicals are thought
to be generated in vivo from the combination of iron
ions (or copper ions), hydrogen peroxide and a re-
ducing agent (e.g., ascorbate) by the Fenton reaction.
This mixture is an aggressive oxidant and will oxidize
many biological molecules, including unsaturated
fatty acids. The high reactivity of the hydroxyl rad-
ical makes it a relatively unselective oxidant and re-
acts with many biomolecules at rates approaching
the di¡usion limit. This means that in order for
any scavenger to have a competitive advantage as a
hydroxyl radical scavenger it has to be present in
millimolar concentrations. Nitric oxide will react
with the hydroxyl radical at di¡usion limited rates
to generate nitrite, but it clearly cannot exist in
vivo at a high enough concentration to be an e¡ec-
tive scavenger. Nitric oxide has been shown to inhibit
the Fenton reaction by binding to ferrous iron and
thus preventing the formation of hydroxyl radical
[22]. The relevance of this mechanism to in vivo con-
ditions has not been established.
4.1.4. Peroxynitrite
In addition to inhibiting the initiation of lipid per-
oxidation, nitric oxide may also enhance this process.
The reaction between nitric oxide and superoxide
generates peroxynitrite [23]. This molecule is a
powerful oxidant that exhibits complex chemistry
with biological molecules. Reaction of peroxynitrite
with unsaturated fatty acid-containing liposomes re-
sults in the initiation of lipid peroxidation [14,24]. In
addition, exposure of low-density lipoprotein to ei-
ther peroxynitrite [25] or SIN-1 [14] (a compound
that generates nitric oxide and superoxide simultane-
ously [26]) results in the oxidation of unsaturated
fatty acids. The mechanism of initiation is unclear
but may involve either abstraction of a bis-allylic
hydrogen by the ‘the hydroxyl radical-like’ activity
peroxynitrite, or induced homolysis of peroxynitrite
by the unsaturated fatty acid.
Peroxynitrite will also rapidly oxidize tocopherols.
Consequently, in a lipid membrane, one of the ¢rst
actions of peroxynitrite is to remove the endogenous
low molecular mass antioxidant protection mecha-
nism. K-Tocopherol is oxidized by two electrons to
K-tocopheryl quinone, a form that is not easily re-
paired by cellular reductants [27].
4.1.5. Nitrogen dioxide
The reaction between nitric oxide and molecular
oxygen generates nitrogen dioxide (cNO2), in combi-
nation with radical^radical combination products,
dinitrogen trioxide and dinitrogen tetroxide. It has
been known for some time the nitrogen dioxide is
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able to initiate lipid peroxidation [28]. The question
of whether the reaction of nitric oxide with oxygen is
biologically relevant is an ongoing debate.
4.2. Nitric oxide and the propagation of lipid
peroxidation
As mentioned above, the rate of propagation of
lipid peroxidation depends strongly on the steady
state concentration of lipid peroxyl radicals. It has
been demonstrated that the radical^radical reaction
between nitric oxide and organic peroxyl radicals is
almost di¡usion limited and generates a transient
ROONO species. This species is thought to undergo
homolytic cleavage to give an alkoxyl radical (ROc)
and nitrogen dioxide [29]. The rate constant for this
reaction in aqueous solution has been determined to
be 1^3U109 [30]. It may be thought, therefore, that
nitric oxide would enhance lipid peroxidation as both
the alkoxyl radical and nitrogen dioxide are able to
oxidize unsaturated lipid. However, experiment has
demonstrated that nitric oxide is a potent inhibitor
of the propagation reaction [31] [32^36]. The most
likely explanation for this observation is peroxyl rad-
ical scavenging. It was recently demonstrated that
the stoichiometry of the reaction between nitric oxide
and peroxyl radical is approximately 2:1 [37]. It was
suggested that ROONO has two fates; (i) internal
rearrangement to give the more stable RONO2 (a
1:1 stoichiometry) and (ii) homolytic cleavage of
the O^O bond to give ROc and nitrogen dioxide.
Either the alkoxyl radical, or a product of this rad-
ical (such as an epoxyallylic^peroxyl radical) would
be expected to propagate lipid peroxidation. How-
ever these species may further react with nitric oxide
to prevent propagation. Nitrogen dioxide is also
known to react with nitric oxide to generate dinitro-
gen trioxide which, in the absence of any other
target, will hydrolyze to nitrite anion. This second
pathway has a stoichiometry of 3:1 or 4:1. A combi-
nation of the above pathways was suggested to be
responsible for the observed 2:1 stoichiometry [37].
5. Nitric oxide and lipid oxidation in pathophysiology
In light of the potent inhibitory e¡ect of nitric
oxide on the propagation of lipid peroxidation, it is
not certain that the lipid peroxidation chain reaction
could ever proceed in the presence of physiological
concentrations of nitric oxide. Kinetic considerations
imply that nitric oxide is a 104^105 times more potent
peroxyl radical scavenger than is K-tocopherol, and it
has been demonstrated that the slow generation of
nitric oxide is able to inhibit the oxidation of K-to-
copherol upon exposure to oxidants [36].
Although lipid peroxidation has been implicated to
be a deleterious component of many oxidative in-
£ammatory disorders, in most cases lipid oxidation
has not been regarded as a causative step in the
progression of the disease. One exception to this is
atherogenesis, where lipid oxidation has been sug-
gested to be a mechanistic component of the forma-
tion of fatty streaks and atheroma [38]. It follows,
therefore, that nitric oxide should play a protective
role in atherosclerosis. All available evidence to date
suggests that compromised endothelial nitric oxide
formation is an early lesion in atherosclerosis and
that the disease can be ameliorated by restoration
of nitric oxide synthesis [39^41]. In addition, chronic
inhibition of nitric oxide formation is pro-atherogen-
ic in cholesterol fed rabbits [42,43]. Although nitric
oxide may work at several levels during atheroscle-
rosis, it is possible that its initial protective e¡ect is
the suppression of lipid oxidation. It has been dem-
onstrated that nitric oxide is a potent inhibitor of
LDL oxidation when initiated by both cellular and
chemical systems [31,44,45]. In addition, nitric oxide
can protect cells against the toxic e¡ects of oxidized
LDL on endothelial cells [46].
Elevation of endothelial superoxide generation, by
several mechanisms, is thought to be an initial com-
ponent of the atherosclerotic process [47]. In addi-
tion, a substantial body of evidence suggests that
nitric oxide and superoxide react rapidly in biological
systems. It follows that superoxide elevation will re-
sult in a decrease in nitric oxide levels. Reduction in
available nitric oxide will reduce any bene¢cial e¡ects
in the suppression of lipid peroxidation. In addition,
the peroxynitrite that is formed from the reaction
between nitric oxide and superoxide may add to
the oxidative stress in the vessel wall. Elevation of
endothelial superoxide is consequently a double-
edged sword [48].
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6. Conclusions
The multiple e¡ects of nitric oxide on the process
of lipid peroxidation imply that the net result will
depend on the balance of competing factors. The
rate and location of nitric oxide formation, and
also the rate of formation of superoxide, or other
mitigating factors, will all contribute to the degree
of lipid oxidation in a particular system. It is highly
likely, however, that the basal activity of endothelial
nitric oxide synthase represents an antioxidant mech-
anism to suppress lipid peroxidation and any conse-
quent cardiovascular dysfunction.
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